ESSA Pharma Inc.
EPIXDelisted Oct 9, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001633932
ESSA Pharma Inc. was delisted on Oct 9, 2025; its insiders filed their last Form 4 on Oct 15, 2025; 32 institutions reported holding it in 13F filings for Q3 2025, worth $4.30M in total; no superinvestor held it.
13F holders, Q4 2024
Institutional positions in ESSA Pharma Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- +13 vs. Q3 2024
- Shares held
- 32.8M
- −2.27M (−6.5%) vs. Q3 2024
- Total value
- $58.8M
- −$154.0M (−72.4%) vs. Q3 2024
- New holders
- 23
- 8 more added
- Sold out
- 10
- 5 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EPIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 32 | $4.30M |
| Q2 2025 | 36 | $52.7M |
| Q1 2025 | 36 | $50.1M |
| Q4 2024 | 45 | $58.8M |
| Q3 2024 | 32 | $212.7M |
| Q2 2024 | 31 | $185.1M |
| Q1 2024 | 33 | $297.5M |
| Q4 2023 | 31 | $229.4M |
| Q3 2023 | 36 | $103.4M |
| Q2 2023 | 39 | $89.8M |
| Q1 2023 | 37 | $98.3M |
| Q4 2022 | 45 | $84.1M |
| Q3 2022 | 54 | $62.2M |
| Q2 2022 | 59 | $119.0M |
| Q1 2022 | 70 | $229.9M |
| Q4 2021 | 60 | $530.1M |
| Q3 2021 | 75 | $297.4M |
| Q2 2021 | 80 | $976.0M |
| Q1 2021 | 70 | $895.7M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding ESSA Pharma Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 21 | $38 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 355 | $635 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 918 | $1.00K | 0.00% | −39,879−97.7% | Reduced |
| Laurel Wealth Advisors LLC | 600 | $1.07K | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 900 | $1.62K | 0.00% | 00.0% | Unchanged |
| CIBC Private Wealth Group, LLC | 2,500 | $4.55K | 0.00% | 00.0% | Unchanged |
| Truvestments Capital LLC | 3,941 | $7.05K | 0.00% | +3,095+365.8% | Added |
| Federation des caisses Desjardins du Quebec | 4,050 | $7.25K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 6,000 | $10.7K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 7,074 | $12.7K | 0.00% | +1,465+26.1% | Added |
| 49 Wealth Management, LLC | 11,172 | $20.0K | 0.00% | +11,172 | New |
| Squarepoint Ops LLC | 14,525 | $26.0K | 0.00% | +14,525 | New |
| Acadian Asset Management LLC | 15,687 | $28.0K | 0.00% | +15,687 | New |
| Two Sigma Securities, LLC | 15,943 | $28.5K | 0.01% | +15,943 | New |
| GTS Securities LLC | 16,700 | $29.9K | 0.00% | +16,700 | New |
| Susquehanna International Group, LLP | 17,704 | $31.7K | 0.00% | +17,704 | New |
| FNY Investment Advisers, LLC | 25,000 | $44.0K | 0.02% | +25,000 | New |
| Prelude Capital Management, LLC | 25,000 | $44.8K | 0.00% | +25,000 | New |
| Cubist Systematic Strategies, LLC | 26,287 | $47.1K | 0.00% | +26,287 | New |
| Geode Capital Management, LLC | 26,858 | $48.1K | 0.00% | 00.0% | Unchanged |
| Lepercq De Neuflize Asset Management LLC | 30,200 | $54.1K | 0.04% | +30,200 | New |
| Group One Trading, L.P. | 36,348 | $65.1K | 0.00% | +8,553+30.8% | Added |
| XTX Topco Ltd | 37,526 | $67.2K | 0.01% | +37,526 | New |
| Jane Street Group, LLC | 45,810 | $82.0K | 0.00% | +45,810 | New |
| American Century Companies Inc | 46,373 | $83.0K | 0.00% | −279−0.6% | Reduced |
| Schonfeld Strategic Advisors LLC | 48,843 | $87.4K | 0.00% | −229,157−82.4% | Reduced |
| Vazirani Asset Management LLC | 50,000 | $89.5K | 0.28% | +50,000 | New |
| Magnus Financial Group LLC | 55,206 | $98.8K | 0.01% | +55,206 | New |
| Two Sigma Advisers, LP | 82,600 | $147.9K | 0.00% | +82,600 | New |
| UBS Group AG | 95,614 | $171.1K | 0.00% | +93,197+3,855.9% | Added |
| Citadel Advisors LLC | 159,041 | $284.7K | 0.00% | +130,562+458.5% | Added |
| BNP Paribas Arbitrage, SA | 164,595 | $294.6K | 0.00% | +120,100+269.9% | Added |
| Marshall Wace, LLP | 181,217 | $324.4K | 0.00% | +181,217 | New |
| Two Sigma Investments, LP | 211,204 | $378.1K | 0.00% | +211,204 | New |
| Aldebaran Capital, LLC | 397,523 | $711.6K | 0.68% | +397,523 | New |
| Bank of America Corp | 812,310 | $1.45M | 0.00% | +812,302+10,153,775.0% | Added |
| RTW Investments, LP | 1,113,002 | $1.99M | 0.03% | −2,148,494−65.9% | Reduced |
| Altium Capital Management LP | 1,428,000 | $2.56M | 0.80% | +1,428,000 | New |
| Pfizer Inc | 1,675,000 | $3.00M | 0.12% | +1,675,000 | New |
| Opaleye Management Inc. | 2,209,998 | $3.96M | 0.69% | +2,209,998 | New |
| Soleus Capital Management, L.P. | 2,262,026 | $4.05M | 0.31% | −2,026,141−47.2% | Reduced |
| Morgan Stanley | 4,195,869 | $7.51M | 0.00% | +14,527+0.3% | Added |
| BML Capital Management, LLC | 4,221,546 | $7.56M | 4.69% | +4,221,546 | New |
| Tang Capital Management LLC | 4,300,000 | $7.70M | 0.51% | +4,300,000 | New |
| BVF Inc | 8,748,629 | $15.7M | 0.53% | 00.0% | Unchanged |
| Bellevue Group AG | 0 | $0 | 0.00% | −7,879,583−100.0% | Sold out |
| PFM Health Sciences, LP | 0 | $0 | 0.00% | −2,742,936−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −1,474,165−100.0% | Sold out |
| Rhenman & Partners Asset Management AB | 0 | $0 | 0.00% | −804,649−100.0% | Sold out |
| Rock Springs Capital Management LP | 0 | $0 | 0.00% | −677,005−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −345,902−100.0% | Sold out |
| CIBC World Markets Inc. | 0 | $0 | 0.00% | −73,587−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −62,955−100.0% | Sold out |
| Kennedy Capital Management, Inc. | 0 | $0 | 0.00% | −41,092−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −5,162−100.0% | Sold out |